BioXcel Therapeutics, Inc. (BTAIQ) vs China SXT Pharmaceuticals, Inc. (SXTC)
BioXcel Therapeutics, Inc. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. China SXT Pharmaceuticals, Inc. is the larger, with a market value of $3.5M against $2.3M — 1.5× the size. BioXcel Therapeutics, Inc. grew revenue faster over the last twelve months: −14.5% against −54.0%. China SXT Pharmaceuticals, Inc. has the higher net margin (−255.2% vs −9,549.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, China SXT Pharmaceuticals, Inc. leads on 9 and BioXcel Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | BTAIQ | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.10% | 36.69% | 53.94% |
| Operating margin | (6,054.72%) | 0.00% | 0.00% |
| Net margin | (9,549.87%) | (255.16%) | 0.00% |
| Free cash flow margin | (6,860.38%) | 0.00% | 0.00% |
| Return on equity | 63.52% | 0.00% | (0.40%) |
| Return on assets | (259.62%) | 0.00% | (3.32%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack